Seres Therapeutics, Inc. Adjustments to Additional Paid in Capital, Warrant Issued
Seres Therapeutics, Inc. (MCRB) reported Adjustments to Additional Paid in Capital, Warrant Issued of $2.79 million for the 12-month period ending 2023-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-03-12
- Seres Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2023-06-30 was $2.79M.
- Seres Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2015-12-31 was $0.00.
- Seres Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for the quarter ending 2015-09-30 was $0.00.
- Seres Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2023 was $2.79M.
- Seres Therapeutics, Inc. adjustments to additional paid in capital, warrant issued for fiscal 2015 was $1.59M.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 6 month | Adjustments to Additional Paid in Capital, Warrant Issued 9 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|---|---|
| 2023-12-31 | $2.79M 10-K · filed 2026-03-12 | |||
| 2023-06-30 | $2.79M 10-Q · filed 2024-11-13 | |||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $0.00 derived: sum of 2 quarters · filed 2018-03-08 | $1.59M 10-K · filed 2018-03-08 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $1.59M 10-Q · filed 2015-11-12 | ||
| 2015-06-30 | $1.59M 10-Q · filed 2015-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B |